SCHEMBL13835372

SCHEMBL13835372

C1CCN2CCN(CC1)CC2

nearest known ligand 0.38

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 1/20 0.38
CA1 P00915 3/20 0.32
CA2 P00918 3/20 0.32
ALDH1A1 P00352 2/20 0.32
HRH3 Q9Y5N1 1/20 0.32
POLB P06746 1/20 0.32
F2 P00734 1/20 0.30
CA12 O43570 1/20 0.30
CA9 Q16790 1/20 0.30
TSHR P16473 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8825927 1.00 MGLL (0.38) MGLLCA1CA2ALDH1A1HRH3
SCHEMBL17603026 1.00 MGLL (0.38) MGLLCA1CA2ALDH1A1HRH3
SCHEMBL12912977 1.00 MGLL (0.38) MGLLCA1CA2ALDH1A1HRH3
SCHEMBL9501105 0.95 MGLL (0.40) MGLLCA1CA2ALDH1A1HRH3
SCHEMBL11219356 0.95 MGLL (0.31) MGLL
SCHEMBL19593693 0.95 MGLL (0.40) MGLLCA1CA2ALDH1A1HRH3
SCHEMBL10926074 0.95 MGLL (0.40) MGLLCA1CA2ALDH1A1HRH3
SCHEMBL19474824 0.95 MGLL (0.40) MGLLCA1CA2ALDH1A1HRH3
SCHEMBL3674229 0.95 MGLL (0.40) MGLLCA1CA2ALDH1A1HRH3
SCHEMBL14433301 0.90 MGLL (0.38) MGLLCA1CA2ALDH1A1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3281933-B1 (METH)ACRYLATE MANUFACTURING METHOD TOAGOSEI CO LTD (JP) 2020-08-19 EP disclosed
US-10619058-B2 Curable composition TOAGOSEI CO., LTD. (JP) 2020-04-14 US disclosed
US-10611856-B2 Curable composition TOAGOSEI CO., LTD. (JP) 2020-04-07 US disclosed
EP-3133058-B1 MULTIFUNCTIONAL (METH)ACRYLATE MANUFACTURING METHOD TOAGOSEI CO LTD (JP) 2019-05-29 EP disclosed
US-10266476-B2 (Meth)acrylate manufacturing method TOAGOSEI CO., LTD. (JP) 2019-04-23 US disclosed
US-10065916-B2 Method for producing (meth)acrylate TOAGOSEI CO., LTD (JP) 2018-09-04 US disclosed
US-20180237629-A1 CURABLE COMPOSITION TOAGOSEI CO., LTD. (JP) 2018-08-23 US disclosed
US-10035752-B2 Multifunctional (meth)acrylate manufacturing method TOAGOSEI CO., LTD. (JP) 2018-07-31 US disclosed
US-20180187026-A1 CURABLE COMPOSITION TOAGOSEI CO., LTD. (JP) 2018-07-05 US disclosed
US-20180171038-A1 CURABLE COMPOSITION TOAGOSEI CO., LTD. (JP) 2018-06-21 US disclosed
US-20180118658-A1 (METH)ACRYLATE MANUFACTURING METHOD TOAGOSEI CO., LTD. (JP) 2018-05-03 US disclosed
EP-3281933-A1 (METH)ACRYLATE MANUFACTURING METHOD Toagosei Co., Ltd. (JP) 2018-02-14 EP disclosed
EP-3269700-A1 METHOD FOR PRODUCING (METH)ACRYLATE Toagosei Co., Ltd. (JP) 2018-01-17 EP disclosed
US-20170204044-A1 MULTIFUNCTIONAL (METH)ACRYLATE MANUFACTURING METHOD TOAGOSEI CO., LTD. (JP) 2017-07-20 US disclosed
EP-3133058-A1 MULTIFUNCTIONAL (METH)ACRYLATE MANUFACTURING METHOD Toagosei Co., Ltd. (JP) 2017-02-22 EP disclosed
US-8506913-B2 Acidic gas absorbent, acidic gas removal device, and acidic gas removal method KABUSHIKI KAISHA TOSHIBA (JP) 2013-08-13 US disclosed
EP-2554243-A1 ACIDIC GAS ABSORBENT, ACIDIC GAS REMOVAL DEVICE, AND ACIDIC GAS REMOVAL METHOD Kabushiki Kaisha Toshiba (JP) 2013-02-06 EP disclosed
US-20120294785-A1 ACIDIC GAS ABSORBENT, ACIDIC GAS REMOVAL DEVICE, AND ACIDIC GAS REMOVAL METHOD KABUSHIKI KAISHA TOSHIBA (JP) 2012-11-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118658-A1 (METH)ACRYLATE MANUFACTURING METHOD MMAB, PAM, MAT2B MGLL 670/4885CA1 907/4885CA2 2624/4885
US-10065916-B2 Method for producing (meth)acrylate MMAB, ADH5, ADH1A MGLL 646/4885CA1 1772/4885CA2 4376/4885
US-20180171038-A1 CURABLE COMPOSITION KAT2B, ACR, GK MGLL 36/4885CA1 1458/4885CA2 2698/4885
US-20180187026-A1 CURABLE COMPOSITION AZI2, KAT2A, KAT2B MGLL 1219/4885CA1 1676/4885CA2 3217/4885
US-10035752-B2 Multifunctional (meth)acrylate manufacturing method MMAB, AMD1, ADH5 MGLL 240/4885CA1 3666/4885CA2 4417/4885
US-10611856-B2 Curable composition ACR, KAT2B, KAT5 MGLL 42/4885CA1 1506/4885CA2 2879/4885
US-20170204044-A1 MULTIFUNCTIONAL (METH)ACRYLATE MANUFACTURING METHOD MMAB, AMD1, ADH5 MGLL 240/4885CA1 3666/4885CA2 4417/4885
US-10266476-B2 (Meth)acrylate manufacturing method MMAB, PAM, MAT2B MGLL 670/4885CA1 907/4885CA2 2624/4885
US-10619058-B2 Curable composition ZMYND8, AZI2, KAT2A MGLL 1127/4885CA1 2249/4885CA2 3863/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.